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Francisella tularensis is a highly-infectious bacterium that causes the rapid, and often
lethal disease, tularemia. Many studies have been performed to identify and characterize
the virulence factors that F. tularensis uses to infect a wide variety of hosts and host
cell types, evade immune defenses, and induce severe disease and death. This review
focuses on the virulence factors that are present in the F. tularensis envelope, including
capsule, LPS, outer membrane, periplasm, inner membrane, secretion systems, and
various molecules in each of aforementioned sub-compartments. Whereas, no single
bacterial molecule or molecular complex single-handedly controls F. tularensis virulence,
we review here how diverse bacterial systems work in conjunction to subvert the
immune system, attach to and invade host cells, alter phagosome/lysosome maturation
pathways, replicate in host cells without being detected, inhibit apoptosis, and induce
host cell death for bacterial release and infection of adjacent cells. Given that the
F. tularensis envelope is the outermost layer of the bacterium, we highlight herein how
many of these molecules directly interact with the host to promote infection and disease.
These and future envelope studies are important to advance our collective understanding
of F. tularensis virulence mechanisms and offer targets for future vaccine development
efforts.
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INTRODUCTION
Francisella tularensis is a Gram-negative intracellular bacterium and the causative agent of the
zoonotic disease tularemia (Carvalho et al., 2014). F. tularensis has been further subdivided into
two subspecies: F. tularensis subsp. tularensis, also referred to as Type A strains which are found
exclusively in North America; and F. tularensis subsp. holarctica, also referred to as Type B strains
which are found throughout the northern hemisphere (Oyston et al., 2004; Keim et al., 2007). Type
A and Type B strains are extremely infectious to humans and can be acquired through various
routes, including arthropod bites, contact with infected animals, ingestion of contaminated food or
water, or inhalation of aerosols (Kingry and Petersen, 2014). Depending on the route of infection,
various organs and tissues are heavily colonized by F. tularensis, including skin, lymph nodes, lungs,
spleen, liver, and kidney, with bacteremia common in the early stages of infection. Disease onset is
typically very rapid with flu-like symptoms common, including fever, headache, chills, malaise, and
sore throat (Dennis et al., 2001).
Because of its low infectious dose, multiple routes of infection, and highmorbidity andmortality
rates, F. tularensis has been designated as a Tier 1 Select Agent by the U.S. Centers for Disease
Control and Prevention (CDC), highlighting concerns over its potential use a bioterrorism agent
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(Dennis et al., 2001). Type A strains are the most virulent
(ID50 < 10 CFU via multiple infection routes in many animals,
including humans; Ellis et al., 2002; Molins et al., 2010), with
the human ulcer isolate, Schu S4, being the most commonly-
used strain in BSL3 laboratories (Molins et al., 2014). Type B
strains are highly-infectious to mice and guinea pigs (pulmonary
and intradermal ID50 < 10 CFU; Ellis et al., 2002; Molins et al.,
2010) but higher doses are needed to infect rabbits (106–109
CFU subcutaneously) and humans (<103 via multiple routes;
Ellis et al., 2002; Petersen and Molins, 2010). Despite these
differences in virulence, Type B strains cause substantially more
infections worldwide (Petersen and Molins, 2010; Hestvik et al.,
2015). An attenuated Type B strain, the live vaccine strain (LVS),
was developed in the former Soviet Union by serial passage
through mice (Eigelsbach and Downs, 1961). Despite its name,
LVS is not licensed for human vaccination in the U.S. due to
safety and efficacy concerns (Oyston, 2009). However, LVS has
been extensively used in research laboratories because of its
ability to be safely used in BSL2 environments, high virulence
in mouse models, high degree of genetic conservation with
virulent Type A and Type B strains, and similar intracellular
replication kinetics as virulent Type A and Type B strains
(Elkins et al., 2007; Jones et al., 2014). A genetically-related
species, Francisella novicida, also can be manipulated at BSL2
and does not cause disease in healthy humans, but F. novicida
has a number of genetic and phenotypic differences that bring
into question its use as a F. tularensis surrogate (Kingry and
Petersen, 2014). The purpose of this review is to summarize the
current knowledge on F. tularensis virulence factors. As such,
we made every attempt throughout this review to clearly note
what strain was used in each of the referenced studies so that
readers can render their own judgments about the applicability to
human disease.
Whereas, F. tularensis is a significant pathogen based on
high morbidity and mortality rates, it also is an extremely
interesting pathogen due its complicated intracellular lifestyle,
ability to infect a wide variety of host cell types, persistence
in the environment, and lack of classical bacterial virulence
factors such as exotoxins or a Type III secretion system
(Celli and Zahrt, 2013). Many excellent reviews previously
have characterized F. tularensis as a “stealth” pathogen, which
first evades host immune detection (Sjöstedt, 2006; Jones
et al., 2014), but subsequently induces a cytokine storm
that causes host death (Cowley, 2009; Cowley and Elkins,
2011). In addition, the metabolic pathways and nutrient
requirements of F. tularensis promoting survival inside host
cells also have been elegantly outlined (Barel and Charbit, 2013;
Barel et al., 2015). Here, we will highlight studies that have
identified and characterized more “classical” virulence factors
of F. tularensis (i.e., those bacterial molecules that directly
interact with the host, directly damage the host, or sense
changes in the environment to modify bacterial gene expression).
This review will begin with the outermost capsular layer and
sequentially discuss the roles of LPS, the outer membrane,
periplasm, and inner membrane in F. tularensis virulence and
disease.
CAPSULE
Polysaccharide capsules are produced by bacteria such as
Escherichia coli, Neisseria meningitidis, and Streptococcus
pneumoniae (Preston and Dockrell, 2008; Willis and Whitfield,
2013), whereas protein capsules are produced by bacteria
such as Bacillus anthracis (Cote et al., 2011). Capsule typically
protects bacteria from complement-mediated lysis, phagocytosis,
and immune recognition. For intracellular pathogens like
F. tularensis, antiphagocytic properties ostensibly may appear
counterproductive, but it is now well-appreciated that “stealth”
pathogens manipulate host cell entry and intracellular trafficking
mechanisms to limit inflammation and promote intracellular
survival (Geier and Celli, 2011; Dai et al., 2013). Conversely,
capsule can elicit protective immunity, as evidenced by successful
capsule-based commercial vaccines against S. pneumoniae,
Haemophilus influenza, and N. meningitidis (McIntyre et al.,
2012). Given the disparate roles of bacterial capsule in virulence
and protective immunity, Francisella capsule has been the focus
of many research studies.
An electron-transparent, capsule-like outer structure,
approximately 0.02–0.04µm thick, was first described by Hood
and shown to play a role in F. tularensis virulence (Hood,
1977). Capsule was observed in F. tularensis strain Schu S4
when bacteria were aerosolized or grown in modified casein
hydrolysate liquid medium. However, capsule was absent from
bacteria exposed to air long-term (20 h), treated with 10%
sodium chloride, or taken from aged cultures (6 months at
4◦C). Biochemical analyses indicated that F. tularensis capsule
was distinct from cell wall material, being composed of ∼51%
lipids (primarily 14 and 16 carbon length fatty acids), up to
35% amino acids, and up to 21% carbohydrates (including
mannose and rhamnose; Hood, 1977). Capsule production
appears to be well-conserved among many F. tularensis strains,
as a monoclonal antibody generated against Schu S4 capsular
material cross-reacted with 14 different Type A and Type B
isolates, including LVS, but did not react against LPS (Apicella
et al., 2010). Detailed analysis of the F. tularensis capsule revealed
polysaccharide identical to the O-antigen subunit of LPS that
diffusely migrated on SDS-PAGE between 100 and 250 kDa
(Apicella et al., 2010). As proof that F. tularensis capsule was
composed of O-antigen and no other LPS components, mass
spectrometry and NMR analyses demonstrated that purified
capsule lacked other LPS-specific components, including 2-
keto-3-deoxyoctulsonic acid (KDO) and lipid A (Apicella et al.,
2010; Bandara et al., 2011). Given the large molecular weight
and identical nature of F. tularensis capsule O-antigen and
LPS O-antigen, F. tularensis capsule appears to be a Group 4
capsule (Whitfield, 2006). As noted above, whereas Schu S4
capsule was found to be composed of mannose and rhamnose,
a LVS capsule-like complex was found to contain mannose,
glucose, and galactose, indicating that capsular composition
may differ between Type A and B species (Bandara et al., 2011).
Together, these studies demonstrated that many F. tularensis
strains express a polysaccharide capsule that it is identical to the
O-antigen but lacks other LPS components.
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Capsule has been shown to play an important role in
F. tularensis virulence both in vitro and in vivo. For Schu
S4, acapsular bacteria were attenuated when guinea pigs were
infected intraperitoneally (i.p.) or when mice were infected
either i.p. or intranasally (i.n.) (Hood, 1977; Lindemann et al.,
2011; Rasmussen et al., 2014). In macrophages, Schu S4
acapsular mutants exhibited reduced cytosolic growth following
phagosomal escape, due to the triggering of apoptotic or
pyroptotic cell death (Lindemann et al., 2011). That study
highlighted the importance of capsule to evade intracellular
detection pathways. Capsule also contributes to LVS virulence,
as serial passage on Chamberlain’s medium increased LVS
capsule production and capsulated LVS was substantially more
virulent in mice via intravenous (i.v.), i.p., or i.n. routes
(Cherwonogrodzky et al., 1994). Similarly, acapsular LVS
mutants were found to be attenuated in macrophages and mice
infected either i.p. or i.n. (Sandström et al., 1988; Bandara et al.,
2011).
Whereas bacterial capsules typically block complement or
antibody from binding to the bacterial surface, the role of
F. tularensis capsule in serum resistance is less clear. In one
study, chemically-mutagenized LVS rough colonies that lacked
electron-dense surface layers (i.e., acapsular mutants) were
susceptible to killing by non-immune human serum, primarily
through the binding of IgM and complement component C3
(Sandström et al., 1988). A second study noted that F. tularensis
spontaneous acapsular mutants absorbed more human serum
components than wild-type capsulated strains and this effect
primarily was mediated by IgM (Sorokin et al., 1996). Finally,
Schu S4 acapsular mutants were found to be serum sensitive
(Lindemann et al., 2011). While these three studies suggest
that F. tularensis capsule blocks antibody and complement
binding to the bacterial surface, other studies have suggested
that serum resistance cannot be solely attributed to capsule.
For example, an acapsular LVS mutant (1FTL1422–1423) was
found to be completely resistant to both guinea pig and human
serum (Bandara et al., 2011). In addition, a number of studies
have noted antibody and/or complement binding to LPS (see
Lipopolysaccharide Section). Based on these conflicting results,
further studies are needed to better understand the role of capsule
in serum resistance.
There has beenmuch interest in identifying the genes involved
in F. tularensis capsule production. However, given the above
referenced studies noting that F. tularensis capsule and O-antigen
polysaccharides are identical, it is not surprising that capsule
gene identification studies have been difficult to interpret or have
yielded conflicting results. A detailed analysis of gene deletion
mutants indicated that wbtA1, wbtA2, wbtC, wbtI, wbtM, and
FTL0708 were required for capsule production, whereas capB,
capC, lpxL, wbtK, FTL0706, and FTT0673–FTT0674 were not
(Apicella et al., 2010; see Table 1 for corresponding gene loci
in Schu S4, LVS, or F. novicida). Of those genes, individual
deletions of wbtA1, wbtA2, wbtC, wbtI, or wbtM resulted in
loss of both capsule and O-antigen, highlighting that capsule
and O-antigen share some biosynthetic pathway components.
Conversely, only the FTL0708mutant was found to be deficient in
capsule production but not LPS, demonstrating that some genes












lpxD2 FTT0286c FTL0196 FTN0200 LPS
flmF2 FTT0454 FTL1611 FTN0545 LPS
flmK FTT0455c FTL1609 FTN0546 LPS
FTT0789 FTL1432 FTN1221 Capsule
FTT0790 FTL1431 FTN1220 Capsule
FTT0791 FTL1430 FTN1219 Capsule
FTT0792 FTL1429 FTN1218 Capsule
FTT0793 FTL1428 FTN1217 Capsule
FTT0794 FTL1427 FTN1216 Capsule
FTT0795 FTL1426 FTN1215 Capsule
FTT0796 FTL1425 FTN1214 Capsule
FTT0797 FTL1424 FTN1213 Capsule
FTT0798 FTL1423 FTN1212 Capsule
FTT0799 FTL1422 FTN1211 Capsule
FTT0800 FTL1421 FTN1210 Capsule
capA FTT0805 FTL1416 FTN1201 unknown
capC FTT0806 FTL1415 FTN1200 unknown
capB FTT0807 FTL1414 FTN1199 unknown
lpxE FTT0891 FTL0393 FTN0416 LPS
waaY FTT1236 FTL0708 FTN1254 Capsule
waaZ FTT1237 FTL0707 FTN1255 LPS
waaL FTT1238 FTL0706 FTN1256 Capsule
wbtM FTT1450c FTL0606 FTN1416 Both
wzx FTT1453c FTL0603 FTN1419 LPS
wbtI FTT1455c FTL0601 FTN1421 Both
wzy FTT1458c FTL0598 FTN1424 LPS
wbtF FTT1459c FTL0597 FTN1425 LPS
wbtE FTT1460c FTL0596 FTN1426 LPS
wbtD FTT1461c FTL0595 FTN1427 LPS
wbtC FTT1462c FTL0594 FTN1428 Both
wbtA2 FTT1463c FTL0593 FTN1430 Both
wbtA1 FTT1464c FTL0592 FTN1431 Both
kdtA FTT1561 FTL0547 FTN1469 LPS
lpxD1 FTT1571c FTL0537 FTN1480 LPS
lpxF FTT1643c FTL1815 FTN0286 LPS
may be capsule-specific. In a separate study, a LVS glycoprotein-
containing capsule-like complex was linked to loci FTL1421–
1432 and deletion of both FTL1422 and FTL1423 resulted in loss
of this capsule-like complex (Bandara et al., 2011). In Schu S4,
loci FTT1236–1238 was shown to be responsible for both O-
antigen production and capsule biosynthesis, of which FTT1236
(waaY) and FTT1238 (waaL) were specifically required for Schu
S4 capsule production (Lindemann et al., 2011). Whereas, the
aforementioned studies focused on polysaccharide or O-antigen-
related genes, a three gene locus named capBCA, homologous to
the B. anthracis poly-γ-D-glutamic acid capsule cap locus, was
found to be required for LVS i.n. virulence in mice (Su et al.,
2007). The capBCA locus is conserved across Type A and B
strains, and mutagenesis studies in Schu S4 and LVS confirmed
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that capBCA or capB mutants were attenuated both in vitro and
in vivo (avirulent by subcutaneous [sub-q], intradermal [i.d.],
and i.n. routes; Su et al., 2007; Jia et al., 2010; Michell et al.,
2010). However, capsule production was not assessed in any of
those virulence studies, bringing into question if the capBCA
locus truly is involved in F. tularensis capsule production. Indeed,
as noted earlier, Apicella et al., found that capB and capC were
not involved in LVS capsule production, suggesting that the cap
genes perform another function. A more recent study suggested
that capA may encode an integral inner membrane protein
that interacts with CapB and CapC to export carbohydrates
extracellularly (Martin-Garcia et al., 2014). Given the large
number of genes and operons that have been reported to play
roles in F. tularensis capsule production, more studies are clearly
needed.
The surface localization of bacterial capsules often has made
them attractive targets for vaccine development efforts. However,
Francisella capsular material has yielded mixed results as a
protective antigen. Schu S4 capsular material did not elicit
protection in guinea pigs or mice against i.p. Schu S4 challenge
(Hood, 1977). However, immunization with LVS capsular
material protected mice from i.p. LVS challenge, despite not
protecting mice from i.p. Schu S4 challenge (Apicella et al., 2010).
The use of capsule-deficient strains as live attenuated vaccines
has yielded more promising results, with a LVS 1FTL1422–1423
strain protecting against high-dose wild-type i.n. LVS challenge
(Bandara et al., 2011) and Schu S4 1waaY and 1waaL strains
protecting against wild-type Schu S4 i.p. and i.n. challenge
(Rasmussen et al., 2014). Importantly, the use of capsule-deficient
mutants as vaccine strains indicates that F. tularensis capsule may
not be a protective antigen but that capsule-deficient mutants
are highly-attenuated and could be safe and effective vaccine
candidates (Bandara et al., 2011). Despite the unlikely role of
the capBCA locus in capsule production, a LVS capBCA mutant
protected mice from wild-type i.n. LVS challenge (Su et al., 2007).
Similarly, both LVS and Schu S4 1capB mutants protected mice
against Schu S4 aerosol and sub-q challenge (Jia et al., 2010;
Michell et al., 2010).
In summary, a majority of studies have demonstrated that
F. tularensis produces a polysaccharide capsule that is identical
to the O-antigen and that capsule is required for F. tularensis
virulence (Figure 1). Despite a number of studies demonstrating
FIGURE 1 | The F. tularensis envelope and its role in virulence. The F. tularensis capsule, identical to the O-antigen of LPS, blocks IgM and complement
component C3 binding. F. tularensis LPS differs from prototypic LPS in that it is tetraacylated, possesses long-chain acyl chains (16–20 carbons long), is either non- or
mono-phosphorylated, and is a weak TLR4 agonist. Type IV pili form horn-like protrusions on the bacterial surface and, while correlated with virulence, the exact
function of F. tularensis type IV pili are not known. A Francisella Pathogenicity Island (FPI)-encoded Type VI-like secretion system has been reported in F. novicida
(Table 3) but expression and function in virulent F. tularensis strains has not been reported. Various proteins have been reported to be secreted by F. tularensis,
including AcpA, KatG, and SodB (Table 3), but the mechanisms for their secretion are unknown. The F. tularensis outer membrane (OM) contains many outer
membrane proteins (OMPs) and outer membrane lipoproteins (OMLps) that are required for virulence (Table 4). Periplasmic and inner membrane proteins (IMPs) also
play roles in F. tularensis virulence (Table 5), but much less is known about these envelope compartments. See individual sections for specific details and references.
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that capsule is required for serum resistance, some controversy
remains about the true role of capsule in serum resistance,
specific composition of the F. tularensis capsule, and the genes
required for capsule production. In addition, some aberrant
findings suggest that multiple capsule-like substances may
be produced by different Francisella strains and that capsule
composition might vary depending on culture conditions or
environmental stimuli. If various capsule compositions do indeed
exist, these capsule variations may be an important part of the
overall virulence strategy of Francisella.
LIPOPOLYSACCHARIDE
Lipopolysaccharide (LPS) makes up the outer leaflet of the outer
membrane for most Gram-negative bacteria. LPS is composed
of three main components; lipid A, core oligosaccharide, and
the O-antigen (Miller et al., 2005). Of these, lipid A (endotoxin)
is highly immunostimulatory and lipid A modifications are a
common virulence strategy for many Gram-negative pathogens
(Tan and Kagan, 2014). E. coli lipid A is the prototype for
many Gram-negative lipid A structures, with six acyl chains
(hexaacylated) that are 12–14 carbons in length. By comparison,
the atypical lipid A of Francisella is tetraacylated with fatty acid
chains 16–18 carbons in length (Vinogradov et al., 2002; Phillips
et al., 2004). These F. tularensis LPS modifications, and others
described below, greatly reduce TLR4 activation and allow for
immune evasion.
A long-recognized F. tularensis blue-gray colony variation
has been shown to correlate with differences in virulence,
host cell stimulation, immunogenicity, and alterations in LPS
(Eigelsbach et al., 1951; Hartley et al., 2006; Soni et al., 2010).
In fact, the highly-virulent Type A strain Schu S4 owes its
“S4” designation to the “S4” smooth blue colony phenotype,
as compared to the “S1” and “S2” smooth buff-colored colony
phenotypes, or “NS” non-smooth gray colony phenotypes that
were isolated from this clinical isolate (Eigelsbach et al., 1951). In
i.p. mouse infection studies, smooth blue Schu S4 variants were
extremely virulent whereas non-smooth gray Schu variants were
six-logs attenuated (Eigelsbach et al., 1951). Gray variants also
have been reported in LVS and these spontaneously-occurring
colony variants were attenuated in rat macrophages due to their
induction of high levels of nitric oxide (NO), as compared
with wild-type LVS which replicated to high numbers in rat
macrophages and induced very little NO (Cowley et al., 1996).
Differences in virulence and macrophage activation appeared
to be due to alterations in lipid A, as purified lipid A from
the LVS gray variant induced more NO than lipid A from
wild-type LVS. In that same study, F. novicida whole bacteria
or purified lipid A from F. novicida were found to induce
more NO than either wild-type LVS bacteria or gray variant
LVS bacteria, demonstrating that F. novicida LPS is distinct
from F. tularensis LPS (Cowley et al., 1996). More recent work
on gray variant LVS determined two key features: first, gray
variants express less LPS O-antigen than wild-type LVS; second,
gray variants have reduced lipid A galactosamine modifications
compared to wild-type LVS. Glycosyltransferase genes flmF2
(FTL_1611) and flmK (FTL_1609) were found to be expressed
at significantly lower levels in gray-variant LVS and deletion
of flmF2 from wild-type LVS reduced the frequency of phase
variation, supporting a role for these glycosyltransferases in
phase variation (Soni et al., 2010). Finally, whereas wild-type
LVS protected mice against Schu S4 i.n. challenge, LVS gray
variants could not, indicating that O-antigen expression levels
and lipid A galactosamine modifications likely are important for
immunogenicity.
Detailed NMR and mass spectrometry studies have revealed
that LPS O-antigen polysaccharide repeats are identical between
Schu S4 and LVS, but differ from F. novicida LPS (Prior et al.,
2003; Vinogradov and Perry, 2004; Thomas et al., 2007; Wang
et al., 2011). The differences in LPS O-antigen are believed to
be due to genomic differences in the wzy, wzx, and wbt loci,
with Schu S4 and LVS both containing 15 O-antigen genes, as
compared to F. novicida which contains 12 O-antigen genes
(Prior et al., 2003; Thomas et al., 2007). For all Francisella strains,
the loci are flanked by transposases and have a lower G-C content
than the rest of the Francisella genome, suggesting possible
horizontal gene acquisition of the O-antigen operon. Deletion
of three highly-conserved LPS O-antigen genes, wbtDEF, in F.
novicida and F. tularensis Schu S4 resulted in attenuation in mice
via a sub-q infection route and loss of LPS O-antigen production
in both bacterial species. However, despite the mutual loss of
LPS O-antigen, only F. novicida wbtDEF mutants were serum
sensitive and only Schu S4 wbtDEF mutants were attenuated
for growth in mouse macrophages (Thomas et al., 2007). In
contrast, whereas LVSwbtDEFmutants also were found to be LPS
O-antigen deficient and serum sensitive, LVS wbtDEF mutants
were not attenuated for humanmacrophage replication (Clemens
et al., 2012). Taken together, these results indicate that although
the Francisella LPS O-antigen is generally required for virulence
in animals, the LPS O-antigen may play subtly different roles in
intracellular survival and serum resistance among the different
Francisella species. Importantly, LPS O-antigen composition
appears to be critical for protective immunity, as F. novicida
LPS protects against i.p. F. novicida challenge, LVS LPS protects
against sub-q LVS challenge, and Schu S4 LPS protects against
sub-q LVS challenge. In contast, F. novicida LPS does not protect
against sub-q LVS or sub-q Schu S4 challenge and Schu S4 LPS
does not protect against i.p. F. novicida challenge (Fulop et al.,
2001; Thomas et al., 2007). The importance of LPS O-antigen in
stimulating protective immune responses was further highlighted
by the fact that vaccinationwith a F. novicida wbtDEFmutant was
unable to protect mice from wild-type F. novicida i.p. challenge
and a SchuS4 wbtDEF mutant was unable to protect mice from
wild-type Schu S4 sub-q challenge (Thomas et al., 2007). Follow-
up studies have confirmed that Schu S4 wbtC and wbtI also play
roles in LPS O-antigen synthesis, as both mutants had altered
or missing LPS O-antigen, were attenuated in mice infected i.d.,
and did not protect against low dose Schu S4 aerosol challenge.
In addition to its role in LPS O-antigen synthesis, wbtC also
appears to play a role in protein glycosylation, as wbtC mutants
displayed fewer glycosylated isoforms of both DsbA (see Outer
Membrane Proteins Section) and PilA (see Type IV Pili Section),
which previously were reported to be glycosylated in F. tularensis
(Twine et al., 2012).
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In most Gram-negative bacteria, lipid A is linked to the
core region through two KDO molecules (Okan and Kasper,
2013). By comparison, the F. tularensis core region contains
only one KDO unit (Vinogradov et al., 2002; Vinogradov and
Perry, 2004). Deletion of the putative core oligosaccharide KDO
transferase gene, kdtA, from Schu S4 resulted in loss of the
core oligosaccharide. Although, kdtA mutants still produced
O-antigen, it was not present on the bacterial surface, supporting
the role of kdtA in core oligosaccharide synthesis. In agreement
with other studies demonstrating the importance of LPS in
virulence and immunogenicity, Schu S4 kdtA mutants were
avirulent in mice via an i.d. infection route but were not
protective against Schu S4 aerosol challenge (Twine et al., 2012).
The lipid A component of Francisella LPS is conserved across
species but possesses key differences from conventional LPS.
First, Francisella lipid A is tetraacylated, as compared to the
hexaacylated lipid A commonly found in most Gram-negatives.
Second, Francisella lipid A acyl chains are 16 to 18 carbons long,
as compared to the 12–14 carbon length chains of conventional
LPS. Third, Francisella lipid A is either non-phosphorylated
or mono-phosphorylated (at the 1′ position), as compared to
prototypic lipid A which is phosphorylated at the 1′ and 4′
positions of the diglucosamine backbone. Fourth, Francisella
masks its 1′ phosphate, if present, by adding galactosamine. The
reduction or absence of negatively-charged phosphates likely
affects the overall charge of Francisella LPS and confers resistance
to antimicrobial peptides (Gunn and Ernst, 2007; Okan and
Kasper, 2013). More comprehensive analyses of Francisella lipid
A have revealed that a variety of structures exist, including acyl
chains of varying lengths (from 14 to 20 carbons) and various
sugar substitutions at the 1′ and 4′ backbone positions (Schilling
et al., 2007; Beasley et al., 2012). Orthologs of the nine E. coli lipid
A synthesis enzymes exist in F. tularensis, indicating that nascent
Francisella lipid A is synthesized with phosphate groups at both 1′
and 4′ positions. However, Francisella actively dephosphorylates
its lipid A at the 1′ position using the LpxE phosphatase and
at the 4′ position using the LpxF phosphatase (Wang et al.,
2004, 2006). The importance of lipid A desphosphorylation as
a virulence mechanism is highlighted by studies demonstrating
that F. novicida lpxF mutants are avirulent in macrophages
and mice (aerosol, i.d., and sub-q infection routes tested) and
are hypersensitive to antimicrobial peptides (Wang et al., 2007;
Kanistanon et al., 2012). As noted above, LPS appears to generate
species-specific immune responses, as the F. novicida 1lpxF
strain protected mice against wild-type i.p. or aerosol F. novicida
challenge but did not confer protection against virulent Type A
or Type B challenge (Kanistanon et al., 2012). Francisella lipid A
also has been reported to be unique from other Gram-negative
lipid A molecules in that 60–95% can be expressed as “free” lipid
A (without core-oligosaccharide or O-antigen) in LVS and F.
novicida (Wang et al., 2006; Lai et al., 2010; Barker et al., 2014).
Whereas, Yersinia pestis has been shown to alter the number
of acyl chains at different temperatures (Rebeil et al., 2006),
Francisella modifies its acyl chain length based on temperature
changes. At environmental temperatures (18◦C), the F. novicida
LpxD2 enzyme adds 16 carbon-length acyl chains to lipid A,
whereas at mammalian temperatures (37◦C), the F. novicida
LpxD1 enzyme adds 18 carbon-length acyl chains. These acyl
chain length modifications appear to be important for virulence
as a F. novicida lpxD1mutant was attenuated in mice via the sub-
q route (Li et al., 2012). It has been speculated that these lipid
A modifications alter the permeability and fluidity of the outer
membrane and may affect outer membrane protein distributions
or interactions, which may help Francisella adapt to survival in
insects and mammalian hosts. Although lpxD1 and lpxD2 genes
exist in Type A and Type B strains, it is unclear if Type A and
Type B strains perform similar carbon chain lengthmodifications
based on temperature.
All of the above modifications appear to be important for
Francisella LPS to minimize recognition by LPS recognition
molecules, including LPS-binding protein, MD-2, and TLR4
(Ancuta et al., 1996; Barker et al., 2006; Hajjar et al., 2006).
Conventional LPS (i.e., E. coli) typically binds to LPS recognition
proteins and induces B-cell proliferation. However, only very
high doses (∼75µg) of F. novicida LPS were able to induce
mouse splenocyte proliferation, demonstrating its weak B-cell
mitogen activity. Interestingly, similar amounts of LVS LPS did
not induce any splenocyte proliferation (Kieffer et al., 2003).
As compared to E. coli LPS, LVS LPS was not found to be
endotoxic by either the Limulus amoebocyte assay or in mice
sensitivity studies (Sandström et al., 1992). Whereas, monocyes
and macrophages produced little to no cytokines in response to
LVS LPS, F. novicida LPS stimulated macrophages to produce
IL-12 and TNFα, highlighting that F. novicida is more pro-
inflammatory than F. tularensis (Sandström et al., 1992; Kieffer
et al., 2003).
Despite LPS modifications to avoid various innate immune
pathways, LVS LPS was reported to activate the classical
complement pathway (Fulop et al., 1993). Complement
activation is a double-edged sword for F. tularensis, as C3b
opsonization is important for host cell phagocytosis but the
bacteria must avoid formation of the membrane attack complex.
Follow-up studies confirmed that complement component
C3 deposits on Schu S4, LVS, and F. novicida, but all three
strains were complement resistant due to rapid inactivation
of complement (conversion to C3bi), which was dependent
on the presence of O-antigen (Clay et al., 2008). F. tularensis
LPS-complement interactions also appear to play a role in
macrophage uptake as, in the presence of complement, wild-
type LVS was phagocytosed by spacious pseudopod loops,
whereas LVS 1wbtDEF or wbtIG191V O-antigen mutants were
phagocytosed by tight overlapping pseudopod layers (Clemens
et al., 2012). As noted above, since the capsule and O-antigen
may share some biosynthetic pathway components, these results
are difficult to interpret. However, these results do suggest
that O-antigen components, either in the capsule or LPS, may
block complement-complement receptor interactions, leading to
altered macrophage uptake mechanisms.
Taken together, Francisella species have evolved distinct
LPS molecules, with a number of structural variations from
prototypic LPS, which promote immune evasion. The inert
nature of Francisella LPS is particularly true for Type A and
Type B strains. Further, many of the outlined studies demonstrate
that specific LPSmodifications contribute to the overall virulence
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strategy of F. tularensis, resulting in high infectivity and severe
disease. Despite the low stimulatory capacity of F. tularensis
LPS, it is interesting to note that this molecule provides species-
specific protection. As such, future vaccine development efforts
may need to consider incorporating anti-LPS responses that
cross-react with both Type A and Type B strains.
TYPE IV PILI
Type IV pili are important virulence factors for many Gram-
negative pathogens, having been shown to play important roles
in bacterial adhesion, aggregation, twitching motility, and DNA
uptake (Craig et al., 2004; Berry and Pelicic, 2015). F. tularensis
type IV pili first were reported in 2004 as “horn-like” surface
structures that were observed when LVS was grown on agar
medium. In contrast, long thin fibers were observed when LVS
was grown in liquid medium, indicating that pili-like structures
may phenotypically vary depending on culture conditions (Gil
et al., 2004). Type IV pili expression also has been reported in
Schu S4 and F. novicida (Zogaj et al., 2008; Ark andMann, 2011),
suggesting that type IV pili are expressed in other Francisella
species. However, there also are indications that pilus expression
may be strain- or lab-dependent, as two publications have
noted that pilus-like structures were not observed on a virulent
F. tularensis subsp. holarctica strain or in F. novicida (Forslund
et al., 2006; Hager et al., 2006).
Genomic sequencing has confirmed the existence of gene
clusters in various Francisella species with homology to the type
IV pilus genes of Neisseria and Pseudomonas (Gil et al., 2004;
Larsson et al., 2005). The Francisella type IV pilus gene clusters
appear to contain 14 genes, including various outer membrane,
inner membrane, ATPase, and pilin subunit proteins. The surface
fiber is composed of between five and six pilin subunits, PilE1–
PilE6 (Gil et al., 2004; Ark and Mann, 2011). Whereas all six
putative pilin genes are present in Type A strains and F. novicida,
Type B strains contain various truncations or deletions of pilE1,
pilE2, or pilE3 (Ark and Mann, 2011). Indeed, LVS is missing
pilE1 and premature stop codons have been introduced into pilE2
and pilE3 (Gil et al., 2004). By comparison, virulent Type B
PilE1 (previously described as PilA) was found to formmultimers
at the bacterial surface and was extensively glycosylated during
animal infections, suggesting that type IV pilin glycosylation
plays an important role in virulence (Forslund et al., 2006). PilO
(also referred to as PglA) was shown to be responsible for PilE1
glycosylation (Egge-Jacobsen et al., 2011). PilE1 has been noted
to be required for full virulence of SchuS4 and a virulent Type
B strain in sub-q mice infections (Forslund et al., 2006, 2010).
The role of PilE1 in F. tularensis virulence is further supported
by work demonstrating that restoration of pilE1, either alone or
in combination with FTT0918 (described in Outer Membrane
Proteins Section), increases LVS virulence (Salomonsson et al.,
2009). Sequence analysis revealed that low-virulence Francisella
strains contain a long pilE4 gene (F. novicida encodes 316 amino
acids; F. tularensis LVS encodes 301 amino acids), whereas high-
virulence strains contain a truncated pilE4 gene (subsp. tularensis
encodes 197 amino acids; subsp. holarctica encodes 211 amino
acids; Zogaj et al., 2008). Despite these differences in amino
acid length, PilE4 appears to be the major pilin component
and was required for type IV pilus assembly in Schu S4, LVS,
and F. novicida (Zogaj et al., 2008; Ark and Mann, 2011).
Interestingly, although PilE4 was required for LVS virulence, it
was not required for Schu S4 virulence in mice via either sub-
q or i.d. infection routes (Ark and Mann, 2011). However, as
noted above, the reason for this virulence difference may be
due to truncated pilE4 in Schu S4. The roles of PilE5 and PilE6
in type IV pili assembly and virulence are less clear, as neither
were required for pili-like fiber assembly or Schu S4 virulence by
either sub-q or i.d. infection routes but both contributed to LVS
virulence by both sub-q and i.d. infection routes (Ark and Mann,
2011).
In addition to the surface-exposed pilin subunits, many
type IV pili assembly proteins also are required for Francisella
virulence. Deletion of either pilC, an inner membrane protein, or
pilQ, an outer membrane protein (Huntley et al., 2007), resulted
in Schu S4 attenuation in sub-q mice infections (Forslund et al.,
2010). Additionally, PilF, the pilus assembly ATPase, and PilT,
the pilus retraction ATPase, both were found to be required for
LVS virulence in i.d. mice infections (Chakraborty et al., 2008).
Interestingly, PilT was not required for Schu S4 virulence in sub-q
mice infection studies (Forslund et al., 2010).
In F. novicida, individual components of the type IV pili
homologous genes have been reported to be involved in a type
II-like protein secretion system (Hager et al., 2006; Zogaj et al.,
2008). Seven proteins were reported to be secreted by this
putative F. novicida secretion system, including two chitinases
(ChiA and ChiB), a chitin binding protein (CbpA), a protease
(PepO), a beta-glucosidase (BglX), and two hypothetical proteins
(Fsp58 and Fsp53; Hager et al., 2006). Although a type II-like
secretion system have not been reported in virulent F. tularensis
strains, it is interesting to speculate that the chitinases and CbpA
may be important for survival or replication in ticks or other
arthropod vectors. In addition, PepO and BglX were found to be
regulated by themaster virulence regulatorMglA, suggesting that
they may play roles in damaging host cells (Hager et al., 2006).
However, the absence of pepO in virulent Type A and Type B
F. tularensis strains suggests that these findings may be unique
to F. novicida.
In summary, there are a number of species-specific variations
in type IV pili genes, media-dependent variations in type IV pili
expression, and conflicting reports about the roles of type IV pili
in F. tularensis virulence. As such, further studies are needed
to better understand F. tularensis type IV pili (summarized in
Table 2 and Figure 1).
SECRETION SYSTEMS AND SECRETED
PROTEINS
Type I Secretion
Type I secretion systems contribute to bacterial virulence
through multi-drug eﬄux and toxin secretion, typified by the
hemolysin secretion system of E. coli or TolC secretion system
in many Gram-negative bacteria (Piddock, 2006; Thomas et al.,
2014; Costa et al., 2015). F. tularensis contains two TolC
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pilC FTT1134 FTL0827 FTN1116 Inner membrane
pilE1 (pilA) FTT0890c absent FTN0415 Pilin subunit
pilE2 (pilE) FTT0889c FTL0391 FTN0414 Pilin subunit
pilE3 (pilV) FTT0888c FTL0390 FTN0413 Pilin subunit
pilE4 FTT0861c FTL0359 FTN0389 Pilin subunit
pilE5 FTT0230c FTL0181 FTN0070 Pilin subunit
pilE6 FTT1314c FTL1475 FTN0664 Pilin subunit
pilF FTT1133 FTL0828 FTN1115 Assembly ATPase
pilO (pglA) FTT0905 FTL0425 FTN1139 PilE1 glycosylase




chiA FTT0715 FTL1521 FTN0627 Secreted proteinb
chiB FTT1786c FTL0093 FTN1744 Secreted proteinb
cbpA FTT1577 FTL0532 FTN1485 Secreted proteinb
pepO absent absent FTN1186 Secreted proteinb
bglX FTT1069c FTL0543 FTN1474 Secreted proteinb
fsp58 FTT0580 FTL1331 FTN0753 Secreted proteinb
fsp53 FTT1330 FTL1491 FTN0647 Secreted proteinb
aA nonsense mutation in the LVS PilT coding sequence has resulted two loci, FTL1771
and FTL1770.
b In F. novicida, individual components of the type IV pili system were reported to be
involved in a type II-like secretion system. See text for more details.
orthologs, TolC and FtlC, both of which are outer membrane-
localized (Huntley et al., 2007). Deletion of either tolC or
ftlC from LVS increased sensitivity to antibiotics, dyes, and
detergents, suggesting that TolC and FtlC play important roles
in F. tularensis drug resistance (Gil et al., 2006). Additionally,
TolC, but not FtlC, was required for LVS i.d. virulence in
mice, indicating that these two TolC orthologs perform non-
redundant functions in F. tularensis (Gil et al., 2006). A later
study found that TolC marginally contributes to Schu S4 i.d.
virulence, as tolC mutants resulted in 2 day-delayed time-to-
death in mice, compared with wild-type infected mice (Kadzhaev
et al., 2009). It remains possible that TolC may secrete yet-to-
be discovered virulence factors, as LVS tolC mutants exhibited
in vivo dissemination and survival defects, were unable to
suppress pro-inflammatory cytokines, and could not inhibit
macrophage apoptosis (Platz et al., 2010; Doyle et al., 2014).
Another F. tularensis outer membrane protein, SilC, originally
named due to homology with silver cation eﬄux proteins in other
bacteria, shares sequence homology with F. tularensis TolC and
FtlC and other bacterial TolC orthologs (Huntley et al., 2007).
However, the role of SilC in F. tularensis secretion or virulence is
unknown.
Type III and Type IV Secretion
Type III and Type IV bacterial protein secretion systems are well-
known to inject bacterial effectors into host cells, either across
the plasma membrane or across internal membranes, promoting
bacterial infection and disease (Raymond et al., 2013; Burkinshaw
and Strynadka, 2014; Christie et al., 2014). Thus far, functional
Type III or Type IV protein secretion systems have not been
described in F. tularensis and Type III or Type IV secretion
system orthologs were not identified in the Schu S4 genome
(Larsson et al., 2005). However, subsequent comparative genomic
analysis found putative Type III effector and Type IV secretion
system homologs in all species of Francisella. Interestingly, three
of the Type III effector homologs and two of the Type IV
secretion system homologs only were present in the avirulent
strains (e.g., F. novicida and F. philomiragia) and were either
truncated or absent from Type A, Type B, and F. tularensis subsp.
mediasiatica strains, suggesting that these Type III and Type
IV secretion system components may not contribute to human
virulence (Champion et al., 2009).
Type VI Secretion
Type VI secretion systems are related to T4-like bacteriophage
injection systems and allow translocation of various effector
proteins into host or competing bacterial cells (Ho et al.,
2014; Russell et al., 2014). Whereas, a putative Type VI
protein secretion system reportedly is encoded by the Francisella
Pathogenicity Island (FPI), F. novicida has been almost
exclusively used in these descriptions (de Bruin et al., 2007;
Barker et al., 2009). The F. novicida Type VI secretion system
appears to be composed of an outer sheath made up of IglA/IglB
heterodimers arranged in a helical cylinder. IglA/IglB sheath
assembly was shown to be initiated by various environmental
signals, including macrophage uptake, 5% KCl, and altered
oxygen tension (Clemens et al., 2015). Structural modeling has
suggested that IglC forms the inner tube of the Type VI secretion
system and contraction of the sheath has been theorized to drive
the inner tube into target membranes (de Bruin et al., 2011;
Clemens et al., 2015). VgrG has been suggested to localize to
the tip of the Type VI secretion system, forming a trimeric host
cell puncturing device (Bröms et al., 2012a). The sheath and tube
complex presumably is anchored to the outer membrane by the
outer membrane lipoprotein IglE (Robertson et al., 2013; Nguyen
et al., 2014). Interestingly, IglE has been shown to interact
with the PdpB and DotU inner membrane protein complex
and studies suggest that IglE and PdpB form a periplasm-
spanning channel (de Bruin et al., 2011; Nguyen et al., 2014). As
expected, each of these Type VI structural components have been
reported to play important roles in virulence, with IglA and IglB
being required for F. novicida phagosomal escape, intracellular
replication, and virulence in chicken embryo and mouse i.d.
infection models (de Bruin et al., 2007; Bröms et al., 2009;
Clemens et al., 2015), DotU and VgrG were necessary for LVS
or F. novicida phagosomal escape and lethal i.d. or i.n. infections
in mice (Barker et al., 2009; Bröms et al., 2012a), and IglE was
required for F. novicida replication inmacrophages and lethal i.n.
infections in mice (Nguyen et al., 2014).
Despite the above studies noting the existence of a F.
novicida Type VI secretion system and its role in virulence,
the exact secreted effectors are still controversial. In one study,
IglC,E,F,I,J, PdpA,E, and VgrG were found to be secreted by LVS
into macrophages in a Type VI secretion-dependent manner.
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However, in that same study, F. novicida only was found to
secrete IglC,E and PdpA,E indicating that there may be species-
specific differences in Type VI secreted effectors (Bröms et al.,
2012b). In contrast, a separate study reported that F. novicida
secreted IglA-J, PdpA,C,E, DotU, and VgrG during macrophage
infections (Hare and Hueffer, 2014). Indeed, the role of VgrG
in Francisella is extremely unclear, with studies indicating that
VgrG is a secreted effector (Barker et al., 2009; Clemens et al.,
2015), coordinates secretion of other effector molecules (Barker
et al., 2009), and/or is a structural component of the Type
VI secretion apparatus (de Bruin et al., 2011; Bröms et al.,
2012a). Understudied FPI and/or Type VI secretion system
components include: IglG and IglI, which were required for
LVS phagosomal escape and in vivo dissemination (Bröms et al.,
2011); and pdpD and anmK, which were required for F. novicida
virulence in chicken embryos and mice (Ludu et al., 2008).
Interestingly, although anmK (predicted chaperone) is found
in F. novicida, anmK is separated into two smaller ORFs in
Type A F. tularensis strains, and anmK is absent from Type B
strains, suggesting that anmK is not required for virulence in
pathogenic F. tularensis strains (Bröms et al., 2010). Additionally,
whereas pdpD (outer membrane protein in F. novicida; Ludu
et al., 2008) is present in both Type A F. tularensis strains and
F. novicida, pdpD has major deletions in Type B strains that
likely result in two, small non-functional proteins (Bröms et al.,
2010).
Secreted Proteins
Various proteins have been reported to be secreted/released
by F. tularensis but the mechanisms for their secretion
are not known. Secretion could occur through one of the
secretion systems outlined above, through outer membrane
vesicle blebbing, or through yet to be elucidated mechanisms.
Some studies have compared the secreted proteome of virulent
and attenuated F. tularensis strains as a means to identify
potential virulence factors. In one study, comparison of culture
filtrate proteins from LVS and Schu S4 revealed three proteins
detected in higher abundance from Schu S4, including the
acid phosphatase AcpA, a beta-lactamase, and hypothetical
protein FTT_0484 (Konecna et al., 2010). In another study,
culture filtrates from a recent type A clinical isolate and LVS
were compared, revealing 12 proteins likely released from
both F. tularensis strains, including catalase-peroxidase KatG,
chaperones DnaK, GroEL, and GroES, superoxide dismutase
SodB, and bacterioferritin Bfr. Of these, KatG and DnaK were
more prevalent from type A strain culture filtrates, Bfr was
detected in multiple isoforms from LVS filtrates, and GroEL
was released at equal levels from both F. tularensis strains.
Interestingly, KatG and GroEL were detected in the cytosol of
infected THP-1 cells, indicating that both may be important for
intracellular replication (Lee et al., 2006).
AcpA has been found to be either associated with the outer
membrane or secreted into culture supernatants by both F.
novicida and LVS (Mohapatra et al., 2007; Dai et al., 2012).
Importantly, AcpA also was isolated from the cytosol of infected
macrophages, suggesting a role in virulence (Konecna et al.,
2010; Dai et al., 2012). In addition to acid phosphatase activity,
multiple functions have been attributed to F. tularensis AcpA,
including phospholipase activity, lipase activity, ability to inhibit
the neutrophil respiratory burst, general roles in intracellular
growth, phagosomal escape, and virulence in animals (via i.n. or
i.p. infection routes; Reilly et al., 1996; Mohapatra et al., 2007,
2008, 2010; McRae et al., 2010).
KatG has been noted to be important for in vitro detoxification
of reactive oxygen and nitrogen species in both LVS and Schu
S4 (Lindgren et al., 2007). As noted above, since Type A strains
were found to express more KatG than LVS (Lee et al., 2006), it is
interesting that LVS was found to be more susceptible to reactive
oxygen and nitrogen species than virulent Type A or B strains
(Lindgren et al., 2007). Despite the hypothetical role of KatG
to protect F. tularensis from free radical damage, KatG was not
found to be necessary for intracellular survival in macrophages
for either LVS or Schu S4, but was required for LVS virulence in
mice via the i.d. route (Lindgren et al., 2007).
Although far fewer studies have been performed to
understand F. tularensis SodB, it has been found to confer
in vitro bacterial resistance to peroxide and the superoxide
generating compound paraquat. In addition, SodB was shown to
be required for LVS virulence in mice by the i.n. route (Bakshi
et al., 2006). The authors of that study proposed multiple modes
of activity for SodB, including binding of free iron to limit highly
lethal hydroxyl radical production, detoxification of superoxide
to limit DNA, protein, and lipid toxicity, and detoxification of
superoxide to prevent peroxynitrite formation (Bakshi et al.,
2006).
Taken together, TolC and the FPI-encoded type VI-like
secretion system appear to be the best candidates for F. tularensis
secretion systems (Figure 1). Although many proteins have been
reported to be released by F. tularensis (Table 3), there are major
gaps in our understanding of F. tularensis secretion mechanisms
and secretion machinery. Whereas studies on the F. novicida
type VI-like secretion system are intriguing and have helped
characterize the functions of various F. novicida FPI genes
(Table 3), parallel studies in virulent F. tularensis strains are
severely lacking, likely due to duplicate copies of the FPI in
Type A and Type B strains. Future studies are needed to better
understand F. tularensis secretion systems, secreted proteins, the
role of the FPI in secretion, and confirm the existence of the Type
VI secretion system in virulent F. tularensis strains.
OUTER MEMBRANE PROTEINS
Because of their surface localization, bacterial outer membrane
proteins (OMPs) can play dual roles as virulence factors and
as immune targets (Huntley et al., 2008; Confer and Ayalew,
2013; Embers and Narasimhan, 2013; Pore and Chakrabarti,
2013; Cash, 2014; Christodoulides, 2014). For these reasons,
many investigators have attempted large-scale proteomic efforts
to identify F. tularensis OMPs, including the use of biotinylation
(Chandler et al., 2015), detergents (Twine et al., 2005b; Dresler
et al., 2011), or sodium carbonate (Pavkova et al., 2005, 2006;
Janovská et al., 2007) to extract and purify surface proteins.
However, in each of those studies, large numbers of cytosolic,
periplasmic, or proteins lacking transmembrane domains were
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sodB FTT0068 FTL1791 FTN1642 Secreted
acpA FTT0221 FTL0158 FTN0090 Secreted
FTT0484 FTL1583 FTN0571 Secreted
β-lactamase FTT0611c FTL0879 FTN1072 Secreted
katG FTT0721c FTL1504 FTN0633 Secreted
ftlC FTT1095c FTL1107 FTN0779 Type I
secretion
silC FTT1258 FTL0686 FTN1277 Type I
secretion











































































































Absent FTN1326 Type VI
secretion
bfr FTT1441 FTL0617 FTN1410 Secreted
groES FTT1695 FTL1715 FTN1539 Secreted
groEL FTT1696 FTL1714 FTN1538 Secreted
tolC FTT1724c FTL1865 FTN1703 Type I
secretion
identified, questioning the utility of those approaches. Despite
these limitations, the following proteins were identified in
three or more studies and are bioinformatically-predicted to
be OMPs: FTT0077, FTT0087, FTT0188, FTT0209c, FTT0472,
FTT0583 (FopA), FTT0721c (KatG), FTT0726c, FTT0842 (Pal),
FTT0901 (Tul4-A), FTT1043 (Mip), FTT1103 (DsbA), FTT1441,
FTT1483c, FTT1484c, FTT1572c, FTT1591, FTT1676, and
FTT1747. To our knowledge, there have been few follow-up
studies on these 19 proteins, so little is known about their true
subcellular localization or their individual roles in virulence.
Gram-negative bacteria are known to spontaneously release
outer membrane vesicles (OMVs) that are highly enriched in
OMPs (Bonnington and Kuehn, 2014), thus it is not surprising
that OMVs have been collected from F. novicida culture
supernatants as a means to identify Francisella OMPs (Pierson
et al., 2011; McCaig et al., 2013). However, mass spectrometry
analysis of F. novicidaOMVs indicated that OMPs compromised
only 5–15% of identified proteins. Importantly, spontaneously-
released OMVs have not been isolated from virulent F. tularensis
strains, indicating that OMV shedding may be F. novicida-
specific. Our laboratory developed and published a rigorous
method to generate F. tularensis OMVs through spheroplasting
and osmotic lysis, followed by OMV isolation using sucrose
density gradient centrifugation (Huntley et al., 2007, 2010). This
powerful technique resulted in the identification of 17 bona
fide F. tularensis OMPs (Huntley et al., 2007) and confirmed
some of the putative OMPs identified from large-scale proteomic
efforts described above (e.g., FopA, KatG, Pal, Tul4-A, Mip,
DsbA; Table 4). Additionally, our laboratory has demonstrated
the protective potential of F. tularensisOMPs to serve as vaccines
against Schu S4 challenge (Huntley et al., 2008).
Aside from the above noted OMPs, the remainder of this
section is devoted to OMPs that have been studied as F. tularensis
virulence factors. FTT1416c first was identified as a F. tularensis
membrane protein (Twine et al., 2005b). The LVS homolog,
FTL0645, was identified from a transposon library as being
required for LVS survival in themouse lung (Su et al., 2007). Later
analysis indicated that FTL0645 (named Flpp3) was a lipoprotein,
stimulated TLR2, and reacted with antisera from LVS vaccinees
and tularemia patients (Parra et al., 2010). The NMR structure of
the Flpp3 Schu S4 homolog, FTT1416c, recently was solved and
found to be structurally similar to the Bet v1 family of allergens,
suggesting that FTT1416c could be a vaccine candidate (Zook
et al., 2015). FTT1416c also was found to contain an internal
hydrophobic cavity, suggesting that FTT1416c could be targeted
for small molecule inhibitor studies (Zook et al., 2015).
Global transcriptional profiling of Schu S4 from mouse
macrophages revealed that FTT0369c (DipA) was upregulated
2- to 3-fold and a 1FTT0369c mutant confirmed that FTT0369c
was required for virulence both in vitro and in vivo (i.n. and i.d.
routes tested in mice; Wehrly et al., 2009). More comprehensive
studies demonstrated that Schu S41dipAmutants escaped from
phagosomes, failed to replicate in the cytosol, and then were
targeted to autophagy vacuoles (LAMP1+, LC3+) for clearance
(Chong et al., 2012). Biochemical and structural analysis of
DipA showed the protein to be outer membrane-localized and
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fslE, srfA FTT0025c FTL1863 FTN1686 Yes
fsaP FTT0119 FTL1658 FTN1596 Yes
dipA FTT0369c FTL1306 FTN0275 Yes
fopA FTT0583 FTL1328 FTN0756 Yes
katG FTT0721c FTL1504 FTN0633
FTT0825c FTL0317 FTN0340
ompA FTT0831c FTL0325 FTN0346 Yes
pal FTT0842 FTL0336 FTN0357
tul4-A FTT0901 FTL0421 FTN0427
FTT0903 FTL0423 FTN0429
tul4-B FTT0904 FTL0424 FTN0430
yapH-N, fupA,
fopC
FTT0918 FTL0439 FTN0444 Yes
yapH-C, fupB FTT0919 FTL0439 FTN0445
mip FTT1043 FTL1042 FTN0921
tolC-A, ftlC FTT1095c FTL1107 FTN0779
dsbA, fipB FTT1103 FTL1096 FTN0771 Yes
pilQ FTT1156c FTL0800 FTN1137






flpp3 FTT1416c FTL0645 FTN1382 Yes
ftaG FTT1573c FTL0535 FTN1482
vacJ FTT1591 FTL1637 FTN0322
iglE FTT1701 FTL1865 FTN1703
tolC-B, tolC FTT1724c FTL0105 FTN1734 Yes
FTT1778c FTL1863 FTN1686
surface-exposed in SchuS4. In addition, DipA was found to
interact with OMP FopA, suggesting that DipA and FopA form
an outer membrane complex (Chong et al., 2013). A more recent
study identifiedDipA as a DsbA substrate and demonstrated that,
although DipA contains a putative lipoprotein acylation motif,
DipA is not lipidated (Ren et al., 2014).
An OmpA-like protein, FTT0831c in Schu S4 and FTL0325
in LVS, was found to be surface-exposed in LVS and outer
membrane-localized in Schu S4 (Mahawar et al., 2012).
FTL0325 and FTT0831c are required for macrophage replication
and deletion of the gene in each respective strain caused
increased proinflammatory cytokine production in macrophages
(Mahawar et al., 2012). Ectopic expression of FTT0831c in
a mammalian cell line blocked NFκB translocation to the
nucleus and suggested that FTL0325/FTT0831c functions to
suppress proinflammatory cytokine responses in host cells
(Mahawar et al., 2012). The LVS FTL0325 mutant was attenuated
in an i.n. mouse infection model, yet still induced high
levels of inflammatory cytokines from days one through four
post-infection, as compared to wild-type LVS or other LVS
mutants (Mahawar et al., 2013). These early pro-inflammatory
cytokine responses to FTL0325 were found to correlate with
protection against Schu S4 challenge. A later study noted that
FTT0831c/FTL0325 mutants had reduced viability in laboratory
medium, resulted in small colony phenotypes on agar, were
larger and more spherical than wild-type cells, and had an
irregular morphology with blebs near the bacterial midpoint
and enlarged bacterial tips. Based on these abnormalities, the
authors proposed that FTT0831c/FTL0325 acts as a structural
protein to link the F. tularensis outer membrane to peptidoglycan
(Robertson et al., 2014). The authors’ results suggested that
loss of FTT0831c/FTL0325 resulted in altered cell morphology
and decreased viability, likely resulting in increased release or
exposure of PAMPs, which may have explained the increased
proinflammatory cytokine response previously observed.
FTT0918 first was characterized as a 58-kDa protein required
for Schu S4 virulence in vitro and in vivo (i.d. mice infections;
Twine et al., 2005a). Interestingly, in LVS, the FTT0918
homolog is C-terminally truncated and fused in-frame with
the N-terminally truncated downstream FTT0919 homolog,
resulting in a hybrid protein FTL0439 (Twine et al., 2005a;
Huntley et al., 2007). Despite coding differences between Schu
S4 and LVS, FTT0918 and FTL0439 both are outer membrane-
localized (Huntley et al., 2007). The importance of FTT0918
in F. tularensis virulence was further highlighted by a study
that reintroduced PilA and FTT0918 into LVS, which restored
virulence to wild-type Type B levels (Salomonsson et al., 2009).
The F. novicida homolog, FTN0444 (named FopC), appears to
play similar roles in virulence both in vitro and in vivo (i.n. mice
infections; Nallaparaju et al., 2011). In vitro studies demonstrated
that, as compared to wild-type F. novicida, F. novicida FopC
mutants were more susceptible to IFNγ-induced macrophage
killing and had decreased membrane stability (Nallaparaju et al.,
2011). FTT0918 also has been shown to be important for both
siderophore-dependent and siderophore-independent (ferrous)
iron acquisition mechanisms in Schu S4 (Lindgren et al., 2009;
Ramakrishnan et al., 2012). In this context, FTT0918 has been
referred to as FupA, for Fe utilization protein A (Lindgren
et al., 2009). Interestingly, despite its role in iron uptake, fupA
expression is not regulated by iron limitation (Lindgren et al.,
2009; Ramakrishnan et al., 2012). It is well-known that iron is
critical for many intracellular pathogens (Cassat and Skaar, 2013;
Caza and Kronstad, 2013), thus it is not surprising that FupA-
mediated iron uptake was found to be important for Schu S4
virulence both in vitro and in vivo (sub-q and i.d. routes tested
in mice; Lindgren et al., 2009; Ramakrishnan et al., 2012). In
LVS, the homologous hybrid protein, FupA/B, has been shown
to play similar roles in uptake of both ferrous and siderophore-
bound iron (Sen et al., 2010; Ramakrishnan and Sen, 2014).
Similarly, FupA/B was found to be important for intracellular
growth and for LVS virulence in i.p. infected mice (Sen et al.,
2010).
FslE (FTT0025c) is a second F. tularensis OMP (Huntley
et al., 2007) that has been shown to play a role in iron
uptake (Ramakrishnan et al., 2008, 2012; Ramakrishnan and
Sen, 2014). In Schu S4, FslE appears to be primarily responsible
for siderophore-mediated ferric iron acquisition (Ramakrishnan
et al., 2008, 2012). Schu S4 FslE was found to be essential for
growth in iron-limiting conditions and, as compared to FupA
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(FTT0918), FslE expression was increased during growth in iron-
limitation (Ramakrishnan et al., 2008, 2012). By comparison, LVS
FslE appears to play a secondary role in siderophore-mediatated
iron uptake, as FslE was not required for the growth of LVS in
iron-limiting conditions (Sen et al., 2010). Interestingly, a Schu
S4 fslE mutant was not attenuated for intracellular growth or
virulence in sub-q-infected mice, but a fupA–fslE double mutant
was more severely attenuated than a fupA mutant in sub-q
infected mice, suggesting that FslE and FupA play synergistic
roles in vivo (Ramakrishnan et al., 2012). Similarly, LVS fslE
mutants were not attenuated in i.p.-infected mice, but a fslE-
fupA/B double mutant was more severely attenuated than a
fupA/B single mutant in i.p.-infected mice, further supporting
the synergistic roles of FslE and FupA/B in F. tularensis virulence
(Sen et al., 2010).
DsbA (FTT1103) was identified as a putative virulence factor
through a Schu S4 transposon library screen that identified
mutants defective in intracellular growth (Qin and Mann,
2006). A subsequent full-gene deletion confirmed that FTT1103
was required for intracellular survival, phagosomal escape, and
virulence in mice (i.n. and sub-q routes tested; Qin et al., 2009). A
number of follow-up studies have implicated DsbA (FTT1103 in
Schu S4, FTL1096 in LVS, also referred to as FipB) as an essential
F. tularensis virulence factor (Qin and Mann, 2006; Thakran
et al., 2008; Qin et al., 2009, 2011, 2014; Straskova et al., 2009;
Schmidt et al., 2013; Senitkova et al., 2015). However, given the
well-known function of bacterial DsbA proteins to form disulfide
bonds in various substrates, including true virulence factors, it
seems unlikely that F. tularensis DsbA directly promotes host
cell binding, invasion, intracellular survival, or other virulence
functions. Further, F. tularensis DsbA is unusual in that it is
outer membrane-localized and lipidated, as compared to the
periplasmically-localized DsbA in other bacteria (Huntley et al.,
2007; Thakran et al., 2008). F. tularensis DsbA lipidation has
been demonstrated to stimulate the TLR2/TLR1 heterodimer and
induce proinflammatory chemokine expression (Thakran et al.,
2008). Additionally, F. tularensis DsbA has been reported to be
glycosylated, although the role of this glycosylation is unknown
(Balonova et al., 2012). Finally, F. tularensis DsbA is distinct
from other bacterial DsbA orthologs in that it contains an N-
terminal Forskolin-binding protein-N (FKBP-N) dimerization
domain as well as a C-terminal DsbA-like domain (Qin et al.,
2011). The function of the DsbA N-terminal FKBP-N domain
is somewhat controversial, as this domain has been reported
to possess isomerase and chaperone activities, was reported
to be required for DsbA dimerization, and was shown to be
required for virulence in mice by either i.n. or sub-q infection
routes (Qin et al., 2014; Senitkova et al., 2015). Conversely,
other studies have reported that the FKBP-N domain does not
possess chaperone activity, is not required for dimerization, and
is not required for virulence in mice by either i.n. or sub-q
infection routes (Schmidt et al., 2013; Qin et al., 2014). More
thorough analyses are needed to clarify the true function of
the DsbA FKBP-N domain. The C-terminal DsbA-like domain
has been more carefully studied, consistently demonstrating
that the thioredoxin-like CXXC active site motif is required
for in vitro and mouse virulence (i.n. and sub-q routes tested;
Qin et al., 2011; Schmidt et al., 2013). The DsbA-like domain
also has been shown to possess disulfide oxidoreductase activity
(Straskova et al., 2009; Schmidt et al., 2013; Qin et al., 2014).
Work by our laboratory recently revealed that F. tularensis
DsbA is a bi-functional protein, possessing both oxidoreductase
and isomerase activities to correctly form complex disulfide
bonds in over 50 substrates, including some of the above
noted virulence factors (e.g., DipA, FopA, and FTT0831c), type
IV pilus components, pathogenicity island proteins, previously
described OMPs, and 25 hypothetical proteins (many of which
are predicted OMPs). As proof-of-principal that these newly-
identified DsbA substrates were true virulence factors, we
demonstrated that at least two novel proteins, FTL1548 and
FTL1709, were required for LVS i.n. infection of mice (Ren et al.,
2014).
Among other F. tularensisOMPs that have been studied, FsaP
(FTL1658) was shown to be a surface-exposed OMP important
for LVS adherence to epithelial cells (Melillo et al., 2006).
Overexpression of FsaP in E. coli increased bacterial adherence
to epithelial cells, confirming the LVS findings. Interestingly,
despite 98% sequence identity to its LVS and Schu S4 (FTT0119)
homologs, the F. novicida FsaP (FTN1596) homolog has an
amino acid substitution in its signal sequence that appears to
affect FsaP localization and function, as F. novicida FsaP was
not outer membrane-localized and F. novicida did not adhere
to epithelial cells as well as LVS (Melillo et al., 2006). Already
highlighted in the Secretion Systems and Secreted Proteins
Section above are two FPI members and reported components
of a Type VI-like secretion system, outer membrane lipoprotein
IglE (FTT1346/FTT1701) and putative outer membrane protein
PdpD (outer membrane localization only shown in F. novicida;
Ludu et al., 2008). Also highlighted in the Secretion Systems and
Secreted Proteins Section were OMPs and TolC homologs TolC
(FTT1724c), FtlC (FTT1095c), and SilC (FTT1258). Of these,
only TolC has been shown to be involved in virulence.
In summary, the large number of reported F. tularensis
OMPs and studies to understand their function (Table 4)
highlight the importance of OMPs as potential virulence factors
and vaccine targets (Figure 1). Future OMP identification and
characterization studies will help to better understand the
extreme virulence of F. tularensis.
PERIPLASMIC AND INNER MEMBRANE
PROTEINS
In Gram-negative bacteria, the periplasm and inner membrane
(IM) compartmentalize and protect the cytoplasmic contents
from the harsh external environment. In E. coli, more than 300
periplasmic proteins perform a variety of functions, including
folding proteins into their native confirmation, sensing unfolded
or damaged proteins (chaperones), degrading proteins, or
binding/transporting sugars, amino acids, and other nutrients
between the OM and IM (Merdanovic et al., 2011; Goemans et al.,
2014). The IM is vitally important for many processes, including
energy production, lipid biosynthesis, transport of sugars, amino
acids, and other nutrients into the cytoplasm, secretion of
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proteins out of the cytoplasm, and signal transduction (Silhavy
et al., 2010; Luirink et al., 2012). Despite the essential nature
of these proteins for bacterial viability, only a few F. tularensis
periplasmic or IM proteins have been studied and correlated with
virulence.
SodC (FTL0380) is predicted to be a periplasmic protein
related to the copper/zinc-containing superoxide dismutase
family. LVS SodC was found to be important for peroxide
and superoxide resistance in vitro, but was not involved in
reactive nitrogen resistance. In IFN-γ-activated macrophages,
sodC mutants were attenuated for macrophage growth and were
found to be partially attenuated in a mouse i.n. infection model
(Melillo et al., 2009).
RipA (FTL1914), an IM protein, first was identified by
screening a LVS transposon library for mutants that failed to
replicate in alveolar epithelial cells (Fuller et al., 2008). Although
RipA is conserved among all sequenced Francisella strains, it
has few orthologs in other bacteria, and its function is not
completely understood. In vitro analyses demonstrated that
the 1ripA mutant invaded macrophages and epithelial cells as
efficiently as wild-type LVS, but the1ripAmutant had significant
survival defects in both cell types. More specifically, the 1ripA
mutant escaped from phagosomes and re-entered autophagy-
like vacuoles as efficiently as wild-type LVS, but was unable to
survive in the host cell cytoplasm. In vivo, the 1ripA mutant
failed to replicate in mouse lungs following i.n. challenge and
was severely attenuated for dissemination to livers and spleens
of infected mice (Fuller et al., 2008). pH appears to play a
role in the 1ripA cytosolic replication defect, as the 1ripA
mutant replicated similar to wild-type LVS in media at pH 6.2,
but the 1ripA mutant replicated poorly at pH 7.5 (similar to
the pH in the macrophage cytosol). Further, ripA transcription
was found to be upregulated at pH 7.5, compared with gene
expression at pH 5.5 (Fuller et al., 2009). Two studies noted
that RipA plays a role in immune evasion, as the 1ripA mutant
induced inflammasome activation, including IL-1β, IL-18, and
TNF-α, and cell death in macrophages (Huang et al., 2010;
Mortensen et al., 2012). However, in F. novicida, a1ripAmutant
was found to possess aberrant cell morphology and lysed more
readily insidemacrophages thanwild-type F. novicida, suggesting
that 1ripA mutants induced inflammasome activation due to
PAMP release (Peng et al., 2011). A separate study showed
that RipA interacts with and modulates LpxA, a component of
the Lipid A biosynthesis pathway (Miller et al., 2014). Taken
together, it appears that RipA may not actively suppress immune
responses, but instead may modulate lipid A/LPS expression
inside host cells and promote intracellular survival (Miller et al.,
2014).
The KdpDE two component signaling system has been shown
to be important for potassium ion homeostasis and virulence in
diverse bacterial species (Freeman et al., 2013). All F. tularensis
strains encode the IM-bound sensor kinase KdpD (FTT1736c,
FTL1879, FTN1715). However, the tandemly-arranged response
regulator KdpE (FTN1714) only is present in F. novicida and
not in virulent Francisella strains. F. novicida KdpD was shown
to be the primary kinase that phosphorylated the orphan
response regulator PmrA (FTT1557c, FTL0552, FTN1465) and
this phosphorylation increased PmrA binding to pmrA and
pdpD promoters. Phosphorylation of PmrA also was found to
be important for virulence in macrophages and i.n. infection
of mice (Bell et al., 2010). Other studies have confirmed the
role of F. novicida KpdD for in vivo virulence, including in
Drosophila (Moule et al., 2010) and mice (sub-q and i.p. routes
tested; Weiss et al., 2007) infection models. F. novicida 1kdpD
mutants also were found to be more sensitive to reactive oxygen
species, but not antimicrobial peptides in vitro (Moule et al.,
2010).
QseBC is a two-component signaling system found in many
bacterial pathogens that responds to host stress hormones
epinephrine and norepinephrine, as well as the bacterial signal
AI-3 (Clarke et al., 2006; Curtis et al., 2014; Weigel and
Demuth, 2015). In F. tularensis, the IM sensor kinase QseC
(FTT0094c, FTL1762, FTN1617) is not transcriptionally linked
to a response regulator, although homology searches suggest that
PmrA (FTT1557c, FTL0552, FTN1465; described above) may
be a QseB homolog (Durham-Colleran et al., 2010). F. novicida
QseC mutants were found to be attenuated in Drosophila (Moule
et al., 2010) and mice (i.p. and sub-q routes tested; Weiss
et al., 2007) infection models. In LVS, a 1qseC mutant was
extremely serum sensitive, could no longer synthesize high
molecular mass O-polysaccharide in its LPS, and was attenuated
for macrophage growth and virulence in mice via the sub-q
route (Mokrievich et al., 2010). QseC also has been reported
to be important for F. novicida biofilm production (Durham-
Colleran et al., 2010). In a separate study, maprotiline, an
FDA-approved norepinephrine uptake inhibitor, was found to
inhibit F. novicida biofilm production in a QseC dependent
manner and prolonged survival in a mouse i.n. infection model
(Dean and van Hoek, 2015). Due to the broad distribution of
QseC across many pathogenic bacteria, QseC is an attractive
target for anti-virulence drug development efforts (Rasko et al.,
2008; Curtis et al., 2014; Dean and van Hoek, 2015). Indeed,
Schu S4 QseC was found to be upregulated during mammalian
infection and a small-molecule inhibitor of QseC, LED209,
decreased expression of many F. tularensis virulence genes
and attenuated intracellular survival and virulence in mice
in an i.n. infection model (Rasko et al., 2008; Curtis et al.,
2014).
Four other IM proteins, LpxE (Wang et al., 2004), LpxF (Wang
et al., 2006, 2007), KdoH1, and KdoH2 (Zhao and Raetz, 2010),
have been implicated in F. tularensis virulence and antimicrobial
resistance, but their roles in LPS biosynthesis and modification
suggest an indirect role. Finally, although SecY, LolC, and Cht1
were shown to be IM-localized in Schu S4 and LVS (Huntley et al.,
2007, 2010) their roles in virulence are not known.
In summary, given the fairly limited number of studies
performed to identify F. tularensis periplasmic and IM proteins
and examine their roles in virulence (Table 5), more emphasis
should be devoted to studying these potentially-important
proteins. As noted in the beginning of this section, given the large
number of periplasmic proteins in other Gram-negative bacteria
and critical role of IM proteins in bacterial survival, periplasmic
and IM proteinsmay be an understudied area with great potential
to reveal new F. tularensis virulence mechanisms.
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qseC FTT0094c FTL1762 FTN1617 Inner membrane
ripA FTT0181c FTL1914 FTN0157 Inner membrane
secY FTT0345 FTL0256 FTN0259 Inner membrane
kdoH2 FTT0398c FTL0464 FTN0494 Inner membrane
kdoH1 FTT0399c FTL0465 FTN0495 Inner membrane
lolC FTT0404 FTL0474 FTN0502 Inner membrane
cht1 FTT0715 FTL1521 FTN0627 Inner membrane
sodC FTT0879 FTL0380 FTN0405 Periplasm
lpxE FTT0891 FTL0393 FTN0416 Inner membrane
lpxF FTT1643c FTL1815 FTN0286 Inner membrane
kdpD FTT1736c FTL1879 FTN1715 Inner membrane
SUMMARY AND PERSPECTIVES
Since 2001, there has been a surge in research studies conducted
on F. tularensis and its non-pathogenic relative F. novicida.
Whereas, these studies have provided a wealth of information
about many previously unstudied F. tularensis hypothetical
proteins and have revealed novel virulence strategies, major
questions still remain about the true role of many of these
putative virulence factors in Type A and Type B virulent
strains. In this review, we focused on components of the
F. tularensis envelope that have been reported to contribute
to immune evasion, intracellular replication and survival, and
mammalian virulence. Since the envelope is the outermost
layer of F. tularensis, many studies have aimed to identify and
characterize envelope components, given their potential surface
exposure and likely direct interaction with host cell molecules.
First, the F. tularensis capsule has been shown to be identical
to the O-antigen, blocks both IgM and complement component
C3 binding, and is required for in vitro and in vivo virulence
of many F. tularensis strains, including Schu S4 (Figure 1).
However, capsule expression appears to be variable and overlap
between capsule and LPS synthesis pathways (Table 1) brings
into question if F. tularensis capsule is real or if the bacterium
simply expresses free O-antigen that aggregates near the surface.
These questions highlight the need for future studies to better
understand capsule. Second, F. tularensis has evolved a unique
LPS with many structural variations from typical Gram-negative
LPS, including fewer acyl chains (tetraacylated), longer fatty
acid chains (16–20 carbons), and reduced or no lipid A
phosphorylation (Figure 1). Importantly, F. tularensis also is able
to subtly alter expression or components of its LPS, including O-
antigen and lipid A, which affect outer membrane stability and
immunogenicity. Together, these LPS alterations affect animal
virulence, immune activation/evasion, and the enigmatic blue-
gray colony phenotype that plagues the field. As noted above,
since F. tularensis capsule and LPS appear to share some
biosynthetic pathways (Table 1) and serum resistance has been
linked to both capsule and LPS, future studies are needed to
resolve how these envelope components, either separately or
cooperatively, contribute to serum resistance. Third, type IV pili
are responsible for thin fibers or horn-like protrusions observed
on the surface of many F. tularensis strains and have been shown
to be required for F. tularensis virulence (Figure 1). Although
there has been some speculation that components of F. novicida
type IV pili may be involved in a putative type II-like secretion
system, these preliminary findings have not been confirmed
in virulent F. tularensis strains. Interestingly, despite the well-
known role of type IV pili in adhesion, aggregation, twitching
motility, and DNA uptake in other bacteria, similar functions
have not been attributed to F. tularensis type IV pili. Whereas,
a number of studies have demonstrated that F. tularensis type
IV pili are important for Type A and Type B virulence, more
detailed studies are needed to elucidate the mechanisms by
which type IV pili interact with or damage the host. Fourth, a
number of investigators have examined culture filtrate proteins
from various F. tularensis strains and identified proteins that
presumably are secreted (Table 3). Indeed, whereas there is much
interest in identifying F. tularensis secretion systems and secreted
proteins to help explain how the bacterium blocks phagosome-
lysosome fusion or escapes from the phagosome, there still
is a dearth of information about F. tularensis secretion. One
possibility is that the F. tularensis TolC orthologs, including
TolC, FtlC, and SilC (Table 3), function as a Type I secretion
system to release effector molecules (Figure 1). Of these, TolC
has been shown to play a role in Schu S4 and LVS virulence.
Another possibility is that the F. novicida FPI-encoded Type
VI-like secretion system delivers effector proteins to host cells
(Figure 1). However, the existence of a Type VI-like secretion
system in virulent F. tularensis has not been reported. Fifth, at
least 10 OMPs have been shown to be required for F. tularensis
virulence (Table 4 and Figure 1). Although OMP functions are
diverse, these studies highlight the importance of identifying and
characterizing OMP function to better understand F. tularensis
virulence. Sixth, although few studies exist on F. tularensis
periplasmic or inner membrane proteins, the existing studies
indicate that the periplasm plays a key role in detoxifying
free radicals and the inner membrane contains two component
signaling systems important for altering gene expression during
infection (Figure 1).
In conclusion, the F. tularensis envelope is a dynamic
and robust outer structure that protects the bacterium from
immune recognition and clearance, facilitates host cell invasion
and survival, and promotes infection and disease. Despite
many advances over the decades and in recent years, much
more work is needed to better understand the broad host
range, environmental persistence, and extreme virulence of this
complex pathogen.
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